Coronavirus Health Monitoring for Employees and Companies an important component of personnel hygiene concept
Witterswil, 15 July 2020 – Since mid-June 2020 many measures to combat the new coronavirus in Switzerland have been relaxed by the Federal Council, but a residual risk still remains.
The restrictions and additionally implemented hygiene rules required process adjustments in many companies. The individual rules of conduct as well as the absence of numerous customer visits have changed the daily business routine for many companies.
With the notification dated 24. June 2020, the federal government, based on the updated sampling strategy of the FOPH, assumes the costs of molecular biological and serological analyses performed on an outpatient basis and related services for SARS-CoV-2 for persons who meet the suspicion, sampling and notification criteria of the FOPH dated June 24, 2020.
Unfortunately for many companies and enterprises the criteria of the FOPH are not fulfilled, but the daily business must continue nevertheless; Biolytix has put together a special offer for exactly these affected companies.
Companies that want to combine preventive corona measures with a systematic and pragmatic monitoring of their employees can contact us. This ensures not only the safety of the employees, but also the general process safety of the company.
Example of a Possible Monitoring Process
We examine your throat swab samples, which are taken by your company physician, for SARS-CoV-2 using molecular biological methods and thus detect acute infections or potential virus excretion.
In addition, we can also test blood samples taken by your in-house medical team for specific SARS-CoV-2 IgG and IgM antibodies. These indicate survived infections and thus a possible existing immunity.
We would be pleased to prepare a customer-specific offer for the systematic testing of your employees.
